BTIG analysts began covering Arcturus Therapeutics (NASDAQ:ARCT) with a positive outlook, assigning a Buy rating and establishing a price target of $41.00. Currently trading at $16.49 with a market ...

Despite advances in conventional treatment modalities, patients with metastatic CRC often face limited options and poor outcomes. Chimeric antigen receptor-T (CAR-T) cell therapy, initially successful ...

Norovirus is one of those nasty winter bugs that just does not relent. It can survive even the most potent of hand gels, as ...

Antigen recognition plays a key role in both the innate and adaptive immune systems. Antigens are small molecular components of cells or non-cellular biological materials. Most often, they are parts ...

The H Mart in Davis Square will open to the public this week, the grocery store chain announced on social media. Customers will get to peruse the aisles of the Asian supermarket on Thursday ...